Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Schizophrenia—An Overview
Robert A. McCutcheon, Tiago Reis Marques, Oliver Howes
JAMA Psychiatry (2019) Vol. 77, Iss. 2, pp. 201-201
Closed Access | Times Cited: 961

Showing 1-25 of 961 citing articles:

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
Robert A. McCutcheon, John H. Krystal, Oliver Howes
World Psychiatry (2020) Vol. 19, Iss. 1, pp. 15-33
Open Access | Times Cited: 446
Advances in multimodal data fusion in neuroimaging: Overview, challenges, and novel orientation
Yudong Zhang, Zhengchao Dong, Shuihua Wang‎, et al.
Information Fusion (2020) Vol. 64, pp. 149-187
Open Access | Times Cited: 349
Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice
Melis Yilmaz, Esra Yalçın, Jessy Présumey, et al.
Nature Neuroscience (2020) Vol. 24, Iss. 2, pp. 214-224
Open Access | Times Cited: 239
A neuroimaging biomarker for striatal dysfunction in schizophrenia
Ang Li, Andrew Zalesky, Weihua Yue, et al.
Nature Medicine (2020) Vol. 26, Iss. 4, pp. 558-565
Closed Access | Times Cited: 206
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Ellis Chika Onwordi, Els F. Halff, Thomas Whitehurst, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 186
The clinical significance of duration of untreated psychosis: an umbrella review and random‐effects meta‐analysis
Oliver Howes, Thomas Whitehurst, Ekaterina Shatalina, et al.
World Psychiatry (2021) Vol. 20, Iss. 1, pp. 75-95
Open Access | Times Cited: 159
Integrating the Neurodevelopmental and Dopamine Hypotheses of Schizophrenia and the Role of Cortical Excitation-Inhibition Balance
Oliver Howes, Ekaterina Shatalina
Biological Psychiatry (2022) Vol. 92, Iss. 6, pp. 501-513
Open Access | Times Cited: 151
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art
Philip D. Harvey, Marta Bosia, Roberto Cavallaro, et al.
Schizophrenia Research Cognition (2022) Vol. 29, pp. 100249-100249
Open Access | Times Cited: 93
The synaptic hypothesis of schizophrenia version III: a master mechanism
Oliver Howes, Ellis Chika Onwordi
Molecular Psychiatry (2023) Vol. 28, Iss. 5, pp. 1843-1856
Open Access | Times Cited: 83
Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes
Oliver Howes, Connor Cummings, George E. Chapman, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 151-167
Open Access | Times Cited: 79
Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia
Steven M. Paul, Samantha E. Yohn, Michael Popiolek, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 9, pp. 611-627
Closed Access | Times Cited: 78
Overlapping Mechanisms of Action of Brain-Active Bacteria and Bacterial Metabolites in the Pathogenesis of Common Brain Diseases
Tanja Patricia Eicher, M. Hasan Mohajeri
Nutrients (2022) Vol. 14, Iss. 13, pp. 2661-2661
Open Access | Times Cited: 78
Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia
Ping‐Tao Tseng, Bing‐Syuan Zeng, Chao‐Ming Hung, et al.
JAMA Psychiatry (2022) Vol. 79, Iss. 8, pp. 770-770
Open Access | Times Cited: 76
Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis
Felim Murphy, Anurag Nasa, Dearbhla P. Cullinane, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 69
The Role of Diet as a Modulator of the Inflammatory Process in the Neurological Diseases
Antonina Kurowska, Wojciech Ziemichód, Mariola Herbet, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1436-1436
Open Access | Times Cited: 63
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
Oliver Howes, Bernard R Bukala, Katherine Beck
Nature Reviews Neurology (2023) Vol. 20, Iss. 1, pp. 22-35
Closed Access | Times Cited: 46
Development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive impairment associated with schizophrenia
Holger Rosenbrock, Michael Desch, Glen Wunderlich
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1557-1566
Open Access | Times Cited: 43
Comparing the Perspectives of Generative AI, Mental Health Experts, and the General Public on Schizophrenia Recovery: Case Vignette Study
Zohar Elyoseph, Inbar Levkovich
JMIR Mental Health (2024) Vol. 11, pp. e53043-e53043
Open Access | Times Cited: 23
Homotopic functional connectivity disruptions in schizophrenia and their associated gene expression
Mengjing Cai, Yuan Ji, Qiyu Zhao, et al.
NeuroImage (2024) Vol. 289, pp. 120551-120551
Open Access | Times Cited: 17
Neuroinflammation and Schizophrenia: New Therapeutic Strategies through Psychobiotics, Nanotechnology, and Artificial Intelligence (AI)
Freiser Eceomo Cruz Mosquera, Maria Camila Guevara-Montoya, Valentina Serna-Ramirez, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 391-391
Open Access | Times Cited: 15
Efficacy and Safety of Sulforaphane Added to Antipsychotics for the Treatment of Negative Symptoms of Schizophrenia
Jing Huang, AnMei Chen, Hua Jin, et al.
The Journal of Clinical Psychiatry (2025) Vol. 86, Iss. 1
Closed Access | Times Cited: 1
Computational Psychiatry Needs Time and Context
Peter Hitchcock, Eiko I. Fried, Michael J. Frank
Annual Review of Psychology (2021) Vol. 73, Iss. 1, pp. 243-270
Open Access | Times Cited: 97
Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis
José M. Rubio, Georgios Schoretsanitis, Majnu John, et al.
The Lancet Psychiatry (2020) Vol. 7, Iss. 9, pp. 749-761
Closed Access | Times Cited: 90
Impaired neural replay of inferred relationships in schizophrenia
Matthew M. Nour, Yunzhe Liu, Atheeshaan Arumuham, et al.
Cell (2021) Vol. 184, Iss. 16, pp. 4315-4328.e17
Open Access | Times Cited: 83
Aberrant Salience, Information Processing, and Dopaminergic Signaling in People at Clinical High Risk for Psychosis
Oliver Howes, Emily Hird, Rick A. Adams, et al.
Biological Psychiatry (2020) Vol. 88, Iss. 4, pp. 304-314
Open Access | Times Cited: 82
Page 1 - Next Page

Scroll to top